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Abstract
Background: The aim of our study was to investigate the reliability of automated oscillometric blood pressure (BP)
monitoring in the presence and absence of atrial fibrillation (AF) in hypertensive patients.
Methods: BP was measured and compared in 71 randomly selected patients with AF and arterial hypertension
diagnosis, 4 times each by auscultatory and oscillometric (Microlife BP A6 PC with AF detection system) methods.
Results: Study included 71 patients: 36 males (mean age 67.4 years) and 35 females (70.2 years). At the time of BP
measuring procedure, 36 patients were in sinus rhythm (SR) and 35 in AF. In SR patients mean systolic blood pressure
(SBP) was 132 ± 17.9 mmHg with auscultatory method (AM), 137.4 ± 19.4 mmHg with oscillometric method (OM); mean
diastolic BP was 77.1 ± 10.9 mmHg (AM), 78.5 ± 12.2 mmHg (OM), in AF patients mean SBP was 127.5 ± 15.1 mmHg (AM),
133.6 ± 17.4 mmHg (OM); mean diastolic BP was 81.4 ± 9.9 mmHg (AM), 83.5 ± 11.8 mmHg (OM), p = 0.037. The averages
of differences for SBP and DBP in sinus rhythm group were (−5.3 mmHg (95% limits of agreement −27.2 – 16.6)) and (−1.
4 mmHg (95% limits of agreement −12.8 – 10.0)), respectively. In patients with AF the averages of differences for SBP and
DBP were (−6.1 mmHg (95% limits of agreement −23.9 – 11.7)) and (−2.1 mmHg (95% limits of agreement −12.9 – 8.7)),
respectively.
Conclusions: The oscillometric device validated for patients with AF on average gives 5.3 mmHg higher systolic BP
values for patients with SR and 6.3 mmHg higher BP values for patients with AF. However, the limits of agreement
between two methods reveal wide range of random error rates which is a questionable topic in clinical practice, as it
could possibly affect the treatment of arterial hypertension in patients with AF.
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Background
Atrial fibrillation (AF) is the most common sustained
arrhythmia [1–3] with the prevalence of 1–2% in general
population [4, 5] and it is associated with increased mor-
bidity, mortality and rising usage of health care
resources [2]. Arterial hypertension (AH) is one of the
most common aethiological factors for AF [6, 7] increas-
ing the risk of AF for both males and females 1.5 and
1.4 times, respectively [8]. Therefore, early diagnosis and
effective treatment of AH are essential for patients with
AF [7, 9]. Hypertension with concomitant AF increase
the risk of a stroke and require regular measuring and
blood pressure (BP) control. This may be reached by
self–monitoring of BP at home, which is more important
than measuring BP at a clinic [9]. Moreover, measuring
BP at home may ensure more precise treatment of AH
and it may also help to diagnose AH early [10]. In the
clinical setting BP is usually measured using manual or
automatic devices [11]. Oscillometric method has mark-
edly simplified self–monitoring of BP and it may be a
better choice for measuring BP at home [12]. Although
oscillometric BP–measuring devices are becoming wide-
spread, they may be considered unreliable for the
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patients with AF [13] because the devices measure BP
from a smooth profile of successive pressure waves [14]
and because of high variability of the heart rate and
stroke volume during arrhythmia [15]. Furthermore,
most automatic BP measuring devices are validated and
calibrated only for patients with sinus rhythm (SR) and
even manufacturers recommend caution when the de-
vices are used for patients with arrhythmias [12]. On the
other hand, nowadays more and more special oscillo-
metric BP devices with AF detectors are used in clinical
practice [16].
Previous studies [11, 17] have shown that oscillometric
devices perform satisfactorily in AF, if repeated measure-
ments are performed. Despite that, recent systematic re-
view and meta–analysis [18] demonstrated that there is
limited evidence in studies that validated the automated
BP devices in AF. Meta–analysis concluded that oscillo-
metric devices may be suitable for measuring systolic,
but not for diastolic BP and may be appropriate for
measuring BP at home, but not for office measurement.
Recent study by Pagonas et al. [12] compared the BP
measured by oscillometric device with invasively
assessed BP and concluded that AF does not signifi-
cantly decrease the accuracy of oscillometry after 3 con-
secutive measurements. However, one of their study’s
limitations was that their oscillometric BP measuring de-
vices were not intended for patients with AF.
Methods
The aim of the study
The aim of our study was to investigate the reliability of
automated oscillometric BP monitoring in the presence
and absence of AF in hypertensive patients at our clinic.
We used auscultatory method as reference technique.
Study population
Our cross–sectional study included 71 patients, treated
in Cardiology Department in Vilnius University Hospital
Santariskiu Klinikos since June 2014 to March 2015. In-
clusion criteria were: confirmed diagnosis of nonvalvular
AF and arterial hypertension. Exclusion criteria were:
age less than 18 years, valvular heart disease, coronary
artery disease, cerebrovascular disease, severe heart fail-
ure (New York Heart Association (NYHA) class ≥ III),
hemodynamic instability, marked peripheral artery dis-
ease, clinically significant thyroid disease. AF types were
classified according to the ESC guidelines. All patients
were diagnosed with both AF and AH. Patients with SR
and first time diagnosed AF were patients, which had
AF diagnosed for the first time during this
hospitalization and it was treated by medical or electrical
cardioversion on the same day or few days before the BP
measurement. BP was measured after the procedure,
thus patients were in SR. All patients were allocated into
2 groups according to the heart rhythm at the time of
BP measuring: one group consisted of patients with AF
and another group included the ones in SR. The rhythm
was determined by monitoring ECG before the BP
measurement.
BP measurements
Auscultatory and oscillometric BP measurements were
performed using adult cuff of adequate size which was
placed around the arm at heart level, with its lower edge
2–3 cm above the brachial artery pulsation point, with
the patient lying in a supine position. In order to avoid
venous congestion and to minimize variability in BP, the
time between measurements was determined to be in a
range of 1–5 min.
BP was measured according to international guidelines
[9], a standard auscultatory method was used as a refer-
ence technique, as stated in established validation proto-
cols [19, 20]. After 5 min of rest four auscultatory BP
measurements were performed on the non–dominant
arm. After using the auscultatory method, four oscillo-
metric BP measurements were obtained, using a Micro-
life (BP A6 PC with AF detection system) device
according to the manufacturer’s instructions, again with
the patient in a lying position and using the same arm.
Thus, an overall number of eight measurements were
taken for each patient. The mean systolic and diastolic
BP of these two different measurements was calculated
for comparison. In this study we have also analysed the
BP control. The target/controlled BP value was 140/
90 mmHg or less.
The study was approved by the Local Ethical Commit-
tee of Vilnius University Hospital Santariskiu Klinikos,
Vilnius, Lithuania on 10th of April, 2014, protocol num-
ber EK–19.
Statistical analysis
Results are presented as mean ± standard deviation (SD).
BP values are the mean of 4 consecutive measurements.
Comparison of numeric BP values of patients with and
without AF was performed by paired 2-tailed t-tests with
the 2-tailed significance level set at p = 0.05. BP meas-
urement methods were compared using linear regression
analysis taking auscultatory method as a reference value.
Pearson’s correlation analysis was performed prior linear
regression analysis. The agreement between two
methods was analysed by Bland–Altman method. The
assumptions of normality of differences and other char-
acteristics were checked with a graphical approach. The
resulting graph is a scatter plot in which the difference
of the two paired measurements is plotted against the
mean of the two measurements. Statistical analysis was
performed using SPSS version 17.0.
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Results
Study included 71 patients: 36 males (mean age
67.4 years) and 35 females (70.2 years), suffering from
AF and AH. The mean age of all patients was 68.8 (±9.1)
years, ranging from 51 to 89 years. At the time of the BP
measurement procedure, 36 (50.7%) patients were in SR
and 35 (49.3%) patients had AF. Patients of both groups
did not differ significantly in terms of age, sex, body
mass index (BMI) and rate of smokers. The detailed
characterization of study population is provided in
Table 1. Antihypertensive treatment for patients with AF
and SR was similar. The only difference was that more
patients with SR used ACFI, while more patients with
AF were on CCB, thiazide or loop diuretics and more
patients with AF were on combined medication (2 or 3
drugs in one tablet). The difference was not statistically
significant.
Data obtained by two methods of BP measuring (i.e.
auscultatory method and automated oscillometry) were
compared. It was found that in both groups systolic and
diastolic blood pressure measurements were higher
using oscillometric method (p = 0.007 in SR group and
p < 0.001 in AF group for systolic BP, p = 0.151 in SR
group and p = 0.032 in AF group for diastolic BP)
(Table 2). In SR patients’ group mean systolic BP was
132 ± 17.9 mmHg measured by auscultatory method and
137.4 ± 19.4 mmHg measured with oscillometric device.
Mean diastolic BP was 77.1 ± 10.9 mmHg (auscultatory
method) and 78.5 ± 12.2 mmHg (oscillometric method).
In patients with AF mean systolic BP was 127.5 ±
15.1 mmHg (auscultatory method) and 133.6 ±
17.4 mmHg (oscillometric method), mean diastolic BP
was 81.4 ± 9.9 mmHg (auscultatory method) and 83.5 ±
11.8 mmHg (oscillometric method).
The difference between mean diastolic blood pressure,
measured by auscultative and oscillometric methods did
not differ significantly (p = 0.72), and the difference be-
tween systolic BP was lower in patients with AF (p =
0.19). Patients with controlled BP had a higher difference
between systolic BP values measured by two methods,
compared to patients with not controlled BP, p < 0.05.
Strong correlations were observed in all investigated
pairs (r value range: 0.82 – 0.88) by Pearson’s correlation
analysis. regression model plots reveal that automated
oscillometric BP measuring method and auscultatory
method are in linear association (r2 = 0.71 (95%CI:0.59-
0.82) for systolic BP and r2 = 0.76 (95%CI:0.67-0.85) for
diastolic BP) (Fig. 1).
The mean auscultatory and oscillometry BP readings
are plotted against the difference between these readings
in AF and SR groups by using the Bland-Altman scatter
plot format (Fig. 2). The averages of differences for SBP
and DBP in SR group were (−5.3 mmHg (95% limits of
agreement −27.2 – 16.6)) and (−1.4 mmHg (95% limits
of agreement −12.8 – 10.0)), respectively. While for pa-
tients with AF the averages of differences for SBP and
DBP were (−6.1 mmHg (95% limits of agreement −23.9
– 11.7)) and (−2.1 mmHg (95% limits of agreement
−12.9 – 8.7)), respectively.
Discussion
In this study we analysed the reliability of automated
oscillometric BP measuring in hypertensive patients with
AF and SR, using auscultatory method as a reference
technique. In our sample all patients suffered from AH.
It is known that AH has a higher prevalence in elderly
and the prevalence of coincidence of AF and AH in-
creases with age, however, it may be difficult for elderly
patients to measure their BP by auscultatory method be-
cause of hearing loss or difficulties to fit the cuff prop-
erly [14].
For sustainable measurements in clinical practice, sit-
ting position is recommended and used. We think, how-
ever, that whilst body position may influence absolute
numbers and lessen the difference between systolic and
diastolic blood pressures, the differences between results
of measuring by different methods and their reproduci-
bility as evaluated in this study, does not depend on
Table 1 Characteristics of the Study Population
Variables AF (n, %) SR (n, %)
Number of patients 35 (49.3) 36 (50.7)
Age (years), mean ± SD 67.5 ± 8.8 69.9 ± 9.5
Male 18 (51.4) 18 (50)
Mean value of heart ratea, bpm ± SD 79 ± 12.8 62 ± 6.3
BMI, mean ± SD 29.8 ± 4.8 29.7 ± 4.6
Smokers 9 (25.7) 16 (44.4)
Years of AF, mean ± SD 9.1 ± 7.9 11.9 ± 9.5
AF type:
First time diagnosed 2 (5.7) 2 (5.6)
Paroxysmal 4 (11.4) 8 (22.2)
Persistent 12 (34.3) 26 (72.2)
Permanent 17 (48.6) 0 (0)
Blood pressure correction:
BP <140/90 mmHg 24 (68.6) 23 (63.9)
BP >140/90 mmHg 11 (31.4) 13 (36.1)
Antihypertensive treatment:
ACEIs/ARBs 22 (62.9) 29 (80.6)
Beta–blockers 24 (68.6) 26 (72.2)
CCBs 14 (40) 17 (47.2)
Diuretics 22 (62.9) 17 (47.2)
AF atrial fibrillation, SR sinus rhythm, SD standard deviation, BMI body mass
index, BP blood pressure, ACEIs angiotensin–converting enzyme inhibitors,
ARBs angiotensin II receptor blockers, CCBs calcium-channel blockers
a – Mean value of heart rate, counted of 4 consecutive measurements
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body position. Many BP measurement studies have used
supine position. We chose supine position because the
group with atrial fibrillation was mainly inpatient sub-
jects that were studied before scheduled electrical car-
dioversion, and for patients with this condition it is
usually more comfortable to lie.
The results of our study are controversial comparing
with recent meta-analysis [18], which analysed 566 pa-
tients with AF and showed that automated BP findings
were higher than manual. Our study, as the meta-analysis,
showed that BP measured with oscillometric device was
higher in both AF and SR groups. However, the meta-
analysis concluded that automated BP monitors in AF ap-
pear to be accurate in measuring systolic, but not diastolic
BP [18], which is the opposite from our study results.
Recent cross-sectional study by Hurley and al. [21]
showed that in elderly patients with AF substantially
higher diastolic BP was usual, compared to the general
population, regardless the BP measuring method. How-
ever, results of our study demonstrated that diastolic BP,
measured with oscillometric device, is even higher than
measured using auscultatory method in patients with AF.
In this study several statistical tests were used to com-
pare two different BP measurement methods. Correl-
ation and single linear regression analysis revealed
satisfactory linear relationships between oscillometry
and auscultation. However, this data does not automatic-
ally imply that there is good agreement between these
two methods [22]. In order to investigate the degree of
agreement, we applied the Bland–Altman analysis which
is known, as one of the way for assessing compliance be-
tween two different methods of clinical measurement
[23]. The results revealed that oscillometric method
shows higher negative bias while measuring systolic BP
in both (SR and AF) groups to compare with diastolic
BP (−5.3 mmHg and −6.1 mmHg versus −1.4 mmHg
and −2.1 mmHg, respectively). No significant difference
in bias between SR and AF group was observed. On
average the oscillometry measured BP (SBP/DBP) was
5.3/1.4 mmHg higher for patients in SR and 6.1/
2.1 mmHg higher for patients with AF. Despite the fact
that values of mean differences are low in our data, the
“limits of agreement” [23] reveal debatable random error
rates of oscilometric method for systolic BP (Fig. 2, top
left and bottom left panels). Thus, the systolic BP value
measured by oscillometry may be 27 mmHg higher or
17 mmHg lower in SR group and 24 mmHg higher or
12 mmHg lower in AF group above the BP values mea-
sured by auscultation. This random error is a question-
able topic in clinical practice, as it could possibly affect
the decision in patients’ management.
Current guidelines on treatment of AH [9] recom-
mend repeated BP measurements in patients with
arrhythmia. The study conducted by Grundvold et al.
[24] found that the patients with systolic BP between
130 and 139 mmHg (“high–normal”) had a 1.5-fold risk
of AF and those with systolic BP over 140 mmHg had a
1.6-fold risk, compared to patients with BP below
128 mmHg. In terms of diastolic pressures, patients with
diastolic BP above 80 mmHg had a relative risk of 1.79 for
developing AF, compared with patients with diastolic BP
< 80 mmHg. The study concluded that increased BP over
time may cause a structural and electrophysiological re-
modeling of atria and ventricles, increased pressure in left
atrium may cause atrial dilatation, which may favor the
development of AF. AFFIRM trial [25] also demonstrated
that the optimal BP target in patients with permanent AF
could be higher than in general population [26]. Even
slight differences may determine whether patient requires
more vigorous BP correction, which may lead to lower
rates of cardiovascular events [27] and hopefully AF. Dif-
ferent results obtained by auscultatory and oscillometric
BP measuring methods could be taken into account while
treating AH in patients with AF.
Conclusions
Our data show that agreement between oscillometry and
auscultation is independed of AF. The oscillometric de-
vice which is validated for patients with AF on average
gives 5.3 mmHg higher systolic BP values for patients
with SR and 6.3 mmHg higher BP values for patients
with AF. However, the limits of agreement between two
methods are debatable: the systolic BP value measured
by oscillometry may be 27 mmHg higher or 17 mmHg
lower for patients with SR and 24 mmHg higher or
12 mmHg lower above the BP values measured by aus-
cultation for patients in AF. The wide range of random
error rates is a questionable topic in clinical practice, as
it could possibly affect the treatment of arterial hyper-
tension in patients with AF.
Table 2 Summary statistics of meana blood pressure by different measurements
Groups Systolic BP by auscultatory
method
Diastolic BP by auscultatory
method
Systolic BP by oscillometric
method
Diastolic BP by oscillometric
method
Sinus rhythm 132.1 ± 17.9 77.1 ± 10.9 137.4 ± 19.4 78.5 ± 12.2
Atrial
fibrillation
127.5 ± 15.1 81.4 ± 9.9 133.6 ± 17.4 83.5 ± 11.9
All 129.8 ± 16.7 79.2 ± 10.6 135.5 ± 18.4 80.9 ± 12.2
BP blood pressure; aMean blood pressure (mmHg) of 4 measurements by two methods ± SD
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Fig. 1 Linear regression analysis of oscillometry versus auscultation. Single linear regression models for comparison of oscillometric method
versus auscultation in different patient groups (All patients, Sinus rhythm and Atrial fibrillation). The reference value is blood pressure values
measured by auscultation. Results are divided by systolic and diastolic blood pressure (BP). Linear regression line is presented within 95%
confidence interval
Fig. 2 Bland–Altman analysis: plot of differences between auscultatory and oscillometric blood pressure measuring methods versus the mean of
these two methods. Horizontal line represents mean difference within limits of agreement, which is defined as the mean difference ± 2
standard deviations
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Study limitation
Measurements were not alternated (auscultatory/oscillo-
metric) or randomized, but rather performed in fixed
order – 4 auscultatory followed by 4 oscillometric, thus
introducing a bias relating to the effect of measurement
on the measured values.
Additional file
Additional file 1: The raw data of study patients. The dataset contains
demographic data (e.g. gender, age) and clinical data (e.g. past and
current diseases, blood pressure measurements) of the study patients.
(XLSX 21 kb)
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